Incidence and clinical outcomes of extended duration support in patients with Impella 5.5 - Analysis from the LOQI Registry

Purpose: Impella 5.5 pumps are increasingly used in cardiogenic shock (CS) for extended hemodynamic support (>14 days). Rates of adverse events have not been well-characterized during longer durations of support. Therefore, we sought to define patient characteristics and adverse event rates in short...

Descripció completa

Dades bibliogràfiques

Autors principals:	David Kaczorowski, MD, Vidang P. Nguyen, MD, Aasim Afzal, MD, Scott C. Silvestry, MD, Ahmad Zeeshan, MD, Naveena Yanamala, PhD, Ray Matthews, MD, Rothy Chhim, MS, Sanjeev Aggarwal, MD, Sami I. Somo, PhD, Gavin W. Hickey, MD
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-08-01
Col·lecció:	JHLT Open
Matèries:	Cardiogenic Shock Impella 5.5 Mechanical Circulatory Support Extended support Long duration support Axial flow pump
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2950133426001072
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!